Delivery Order SPE2DB20D1004-SPE2DB22FF5Z4

Award Date 5/3/22
Potential Completion Date 5/4/22
Potential Value $15K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $14,408.18 firm fixed price delivery order is for the supply of PREVNAR 13 syringes, a pneumococcal vaccine, to support military and government healthcare needs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,296.46 firm-fixed-price delivery order is for the supply of PREVNAR 13 syringes (0.5 mL). The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $87,970.84 firm fixed-price delivery order is for the procurement of PREVNAR 13 SYRINGE 0.5ML, a pneumococcal conjugate vaccine. The contract has an ultimate completion date of September 9, 2022 and was awarded on September 8, 2022. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA...
This federal contract award, valued at $3,568.22, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of PREVNAR 13 syringes, a critical vaccine product, with a completion date of January 5, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award, valued at $94,108.64, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of PREVNAR 13 SYRINGE 0.5ML, a pharmaceutical product. The award is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,012.66 Firm Fixed Price delivery order is for PREVNAR 13 SYRINGE 0.5ML, a pneumococcal conjugate vaccine. The contract has an ultimate completion date of May 22, 2023 and was awarded on May 19, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc....
This federal contract award, valued at $42,574.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of PREVNAR 13 SYRINGE 0.5ML, a vaccine product, with a performance period ending on May 15, 2023. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major procurement arm of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $69,742.99 fixed-price delivery order is for the supply of PREVNAR 13 SYRINGE 10S, a pneumococcal vaccine. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $38,318.20, is for the delivery of PREVNAR 13 syringes. This is a firm fixed-price delivery order contract with no set-aside designation, indicating an open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key supplier to various government agencies, particularly the DLA and...
This federal contract award, valued at $22,257.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of PREVNAR 13 syringes, a vaccine product, and is a firm-fixed-price delivery order with a completion date of May 15, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB22FF5Z4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $14,695.12 firm fixed-price delivery order is for the procurement of PREVNAR 13 syringes, a pneumococcal vaccine, to support U.S. government healthcare programs.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. This contract does not have a set-aside designation, indicating it was competed on an unrestricted basis.

Generated 2/27/25, 9:59 AM